MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
124.78%
Quick Ratio
124.78%
Debt to Asset Ratio
80.98%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Deferred offering costs and othe...
    • Prepaid assets and other current...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
4,425,841
8,134,004
13,159,423
16,924,763
Prepaid assets and other current assets
322,100
385,444
483,996
519,237
Total current assets
4,747,941
8,519,448
13,643,419
17,444,000
Deferred offering costs and other assets
451,398
391,838
392,491
269,934
Total assets
5,199,339
8,911,286
14,035,910
17,713,934
Accounts payable
1,076,691
1,201,393
1,524,190
1,245,375
Other accrued expenses
2,304,621
2,602,611
3,567,404
4,259,048
Accrued compensation
386,741
885,813
588,304
846,283
Accrued interest, current
37,143
32,080
27,018
21,956
Total current liabilities
3,805,196
4,721,897
5,706,916
6,372,662
Accrued interest, less current portion
-
-
0
0
License payable
404,991
404,991
404,991
404,991
Total long-term liabilities
404,991
404,991
404,991
404,991
Total liabilities
4,210,187
5,126,888
6,111,907
6,777,653
Common stock, 0.000001 par value, 200,000,000 shares authorized, 24,013,577 and 23,245,203 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
24
24
23
23
Additional paid-in capital
166,089,213
164,017,824
162,531,681
160,990,006
Accumulated deficit
-165,100,085
-160,233,450
-154,607,701
-150,053,748
Total stockholders equity
989,152
3,784,398
7,924,003
10,936,281
Total liabilities and stockholders equity
5,199,339
8,911,286
14,035,910
17,713,934
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$4,425,841 (-31.83%↓ Y/Y)Prepaid assets and othercurrent assets$322,100 (64.42%↑ Y/Y)Total current assets$4,747,941 (-29.01%↓ Y/Y)Deferred offering costsand other assets$451,398 (61.02%↑ Y/Y)Total assets$5,199,339 (-25.39%↓ Y/Y)Total liabilities andstockholders equity$5,199,339 (-25.39%↓ Y/Y)Total liabilities$4,210,187 (-56.25%↓ Y/Y)Total stockholdersequity$989,152 (137.27%↑ Y/Y)Accumulated deficit-$165,100,085 (-14.14%↓ Y/Y)Total currentliabilities$3,805,196 (-58.64%↓ Y/Y)Total long-termliabilities$404,991 (-4.00%↓ Y/Y)Additional paid-in capital$166,089,213 (16.97%↑ Y/Y)Common stock, 0.000001par value,...$24 (20.00%↑ Y/Y)Other accruedexpenses$2,304,621 (-49.58%↓ Y/Y)Accounts payable$1,076,691 (-66.05%↓ Y/Y)Accrued compensation$386,741 (-72.14%↓ Y/Y)Accrued interest,current$37,143 (-47.65%↓ Y/Y)License payable$404,991 (0.00%↑ Y/Y)

ACTUATE THERAPEUTICS, INC. (ACTU)

ACTUATE THERAPEUTICS, INC. (ACTU)